{"schema_version":"secwatch.filing_event.v1","accession":"0001708599-26-000027","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2026-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.782587+00:00","generated_at":"2026-05-15T05:07:42.259885+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Serina appoints CTO, raises CEO salary to $500K, amends bylaws for Co-Chairs","bullets":["Srini Tenjarla, Ph.D., promoted to CTO of Serina (AL) subsidiary; salary increased to $425,000 retroactive to Mar 15, 2026.","CEO Steve Ledger salary raised to $500,000 retroactive to Sept 9, 2024; retro payment made in lump sum Apr 2026.","Bylaws amended to allow one or more Co-Chairs with equal authority to call special meetings and preside."],"urls":{"canonical":"https://secwatch.observer/filing/0001708599-26-000027","json":"https://secwatch.observer/filing/0001708599-26-000027.json","markdown":"https://secwatch.observer/filing/0001708599-26-000027.md","text":"https://secwatch.observer/filing/0001708599-26-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000170859926000027/0001708599-26-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000170859926000027/ser-20260415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:07:42.259885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8fe4ffe832030814133ab7dca3e495ce50125c9e","claim":"Serina Therapeutics, Inc.: Amended and restated bylaws to include provisions relating to appointment and authority of Co-Chairs of the Board of Directors, and conforming updates (effective 2026-04-15).","evidence_excerpt":"On April 15, 2026, the Board of Directors of the Company approved and adopted amended and restated bylaws of the Company (the \" Bylaws \"), effective immediately. The Bylaws include provisions relating to the appointment of Co-Chairs of the Board of Directors, including provisions clarifying that special meetings of stockholders may be called by the Chair or any Co-Chair, that the Chair or any Co-Chair may preside at meetings of stockholders and meetings of the Board of Directors, and that each Co-Chair has the same authority and powers as the Chair of the Board and may act independently of any other Co-Chair, subject to coordination expectations set forth in the Bylaws.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859926000027/0001708599-26-000027-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-04-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}